Given the broad therapeutic window for metformin, it was concluded that the increase in exposure was not clinically relevant, and is likely due to the known effect of GLP-1RAs for delaying gastric emptying
Cagrilintide Structure CAS #: 1415456-99-3 Molecular Formula: CHNOS Molecular Weight: 6781.6 g/mol PubChem ID: 137465331 Research Findings Cagrilintide has been studied in metabolic, endocrine, and systemic models, with research highlighting its role in appetite regulation, energy balance, and weight-related pathways
Safety of drug therapies used for weight loss and treatment of obesity
For Ozempic, prior authorization is required by most insurance plans because the medication is expensive (approximately $1,000 monthly at list price), alternative treatments exist, and insurance companies want to ensure appropriate use